Skip to main content
Silence Therapeutics plc (SLNCF)
OTCMKTS · Delayed Price · Currency is USD
0.9700
0.00 (0.00%)
May 8, 2025, 4:00 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Ribonucleic Acid Therapeutics
42.35M
Log In
Log In
Log In
Log In
Ribonucleic Acid Therapeutics Growth
31.12%
Log In
Log In
Log In
Log In
Research Collaboration - Mallinckrodt Plc
-
Log In
Log In
Log In
Log In
Research Collaboration - Mallinckrodt Plc Growth
-
Log In
Log In
Log In
Log In
Research Collaboration - Other
-
Log In
Log In
Log In
Log In
Royalties
-
Log In
Log In
Log In
Log In
Royalties Growth
-
Log In
Log In
Log In
Log In
Research Collaboration - AstraZeneca
-
Log In
Log In
Log In
Log In

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2024 FY 2023 FY 2022 FY 2021 FY 2020
Period Ending
 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
United Kingdom
42.21M
Log In
Log In
Log In
Log In
United Kingdom Growth
33.68%
Log In
Log In
Log In
Log In
Germany
140.99K
Log In
Log In
Log In
Log In
Germany Growth
-80.54%
Log In
Log In
Log In
Log In